Artelon provides FLEXBAND, a bio‑engineered implant that augments repaired ankle ligaments and tendons with elastic, load‑sharing support. Its patented porous material maintains soft‑tissue tension during dynamic motion while promoting rapid cellular infiltration and full tissue integration over 4–6 years, helping patients regain stable, functional mobility.
Funding
$20M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Patients with ankle instability often require surgical repair, but post‑operative tissues can remain weak, leading to limited mobility, recurrent injuries, and prolonged rehabilitation.
Solution
Artelon offers FLEXBAND, a bio‑engineered implant designed to augment repaired ankle ligaments and tendons. The device provides elastic, load‑sharing support that maintains soft‑tissue tension during active movement without restricting range of motion. Its porous structure encourages rapid cellular infiltration and tissue integration, allowing the implant to become fully incorporated into the body over 4–6 years. By mimicking the natural strength profile of healthy tissue, FLEXBAND promotes stable, functional motion while the native tissue heals and remodels.
Target Audience
Primary customers are orthopedic surgeons and sports‑medicine clinicians performing ankle ligament repair or augmentation, as well as hospitals and surgical centers seeking advanced soft‑tissue support solutions.
Features
- Patented elastic material that delivers consistent tension throughout dynamic ankle motion
- Cell‑specific porosity that accelerates tissue ingrowth and vascularization
- Gradual load transfer to the healing tissue, avoiding over‑stiffening or constraint
- Long‑term biocompatibility with full integration into native tissue within 4–6 years
- Designed for use in a variety of ankle instability repairs and augmentation procedures